CLINICAL NEWS

Improvements in warfarin therapy reduce stroke rate, study shows

Current use of warfarin as a stroke prevention therapy in patients with nonvalvular atrial fibrillation is associated with a lower rate of residual stroke or systemic embolism compared with previous data, according to a recent study published in the Archives of Internal Medicine. » More

CONTINUING EDUCATION

Helping your patients control persistent asthma

Goal: To assist pharmacists and pharmacy technicians to help patients effectively control persistent asthma.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Study compares infection risk for JIA, ADHD patients

Children with juvenile idiopathic arthritis were at twice the risk of infection compared with children with attention-deficit hyperactivity disorder, according to a study published May 1 in Arthritis & Rheumatism. » More

New Drug Price Type Options: White Paper

Two new and different methods to ascertain true drug acquisition cost can save money on Rx drug benefits. Read white paper for details and comparison of NADAC and PAC.

EDITOR’S PICK

FDA updates recommendations regarding coadministration of protease inhibitors and statins

FDA is providing new recommendations regarding the coadministration of statins and protease inhibitors commonly used to treat human immunodeficiency virus (HIV) or hepatitis C. » Click here.

Surgery and therapy improve type 2 diabetes, results show

Bariatric surgery plus medical therapy may be a useful strategy for managing uncontrolled diabetes, according to the results of a recent study published in the New England Journal of Medicine. » More

Youth with type 2 diabetes at risk for add-on therapies

Youth diagnosed with type 2 diabetes may require a combination treatment or insulin therapy within a few years after diagnosis, according to a study published online April 29 in the New England Journal of Medicine. » More

Survey

With specialty drug products representing the fastest growing component of today’s drug expenditures, which of the following would you rate as the most important service a specialty pharmacy can provide in helping to optimize the quality and cost-efficiency of specialty pharmaceutical care?

a) Waste management
b) Patient risk assessment and education
c) Managing prior authorization of specialty products
d) Outcomes monitoring, reporting, and intervention
e) Helping patients navigate financial assistance programs
f) Adherence programs

Click here and see what your colleagues think, too.

Want to see the results of our last survey regarding healthcare industry trends and which one will have the most significant impact on the ability to manage pharmacy expenditures over the next 3-5 years? Click here.

Like us on Facebook

Resources

•	Drug Watch
•	FDA Actions
•	Latest News
•	Medication Safety
•	Policy Watch

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.